Core Points - Nutriband Inc. has been invited to present at the Emerging Growth Conference on August 20, 2025, providing an opportunity for interaction with investors [1][2] - The presentation will be led by Chairman Serguei Melnik and will last for 30 minutes, starting at 09:40 AM Eastern time [3] - Attendees can submit questions in advance or ask during the event, with an archived webcast available for those unable to attend live [4] Company Overview - Nutriband Inc. focuses on developing transdermal pharmaceutical products, with its lead product being an abuse-deterrent fentanyl patch utilizing AVERSA™ technology [7] - AVERSA™ technology aims to prevent the abuse, misuse, diversion, and accidental exposure of drugs with abuse potential [7] Conference Details - The Emerging Growth Conference allows public companies to present their products and major announcements efficiently to the investment community [5] - The conference covers a variety of growth sectors and targets a wide audience, including individual and institutional investors, as well as investment advisors and analysts [6]
Nutriband Inc. to Present on the Emerging Growth Conference on August 20, 2025